Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2022-11-30 00:00:00 ET · period of report 2022-11-29 · accession 0001437749-22-028234 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-30 | 2022-11-29 | BLFS | Rice Michael | CEO, Dir | S - Sale | $19.93 | -931 | 358.5K | -0.3% | -$18.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-29 | S | D | 931 | $19.93 | 358,473 | D | — | — |